These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 38106909)

  • 1. Evolving trends among
    Thomsen J; Menezes GA; Abdulrazzaq NM; ; Moubareck CA; Senok A; Everett DB
    Front Public Health; 2023; 11():1243973. PubMed ID: 38106909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and antimicrobial resistance trends of
    Thomsen J; Abdulrazzaq NM; AlRand H; ; Everett DB; Senok A; Menezes GA; Ayoub Moubareck C
    Front Public Health; 2023; 11():1245131. PubMed ID: 38239785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of vancomycin-resistant enterococci in the United Arab Emirates: a retrospective analysis of 12 years of national AMR surveillance data.
    Thomsen J; Abdulrazzak NM; AlRand H; ; Menezes GA; Moubareck CA; Everett DB; Senok A; Podbielski A
    Front Public Health; 2023; 11():1275778. PubMed ID: 38089023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and antimicrobial resistance of
    Thomsen J; Abdulrazzaq NM; Nyasulu PS; Al Hosani F; Habous M; Weber S; Jabeen F; ; Menezes GA; Moubareck CA; Senok A; Everett DB
    Front Public Health; 2024; 12():1244353. PubMed ID: 38947352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem resistant
    Thomsen J; Abdulrazzaq NM; ; Everett DB; Menezes GA; Senok A; Ayoub Moubareck C
    Front Public Health; 2023; 11():1244482. PubMed ID: 38145078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of highly resistant
    Thomsen J; Abdulrazzaq NM; Oulhaj A; Nyasulu PS; Alatoom A; Denning DW; Al Dhaheri F; ; Menezes GA; Moubareck CA; Senok A; Everett DB
    Front Public Health; 2023; 11():1244358. PubMed ID: 38292390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methicillin resistant
    Thomsen J; Abdulrazzaq NM; ; Menezes GA; Ayoub Moubareck C; Everett DB; Senok A
    Front Public Health; 2023; 11():1244351. PubMed ID: 38145065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of antimicrobial resistance in the United Arab Emirates: the early implementation phase.
    Thomsen J; Abdulrazzaq NM; AlRand H;
    Front Public Health; 2023; 11():1247627. PubMed ID: 38074700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa.
    De Rosa A; Mutters NT; Mastroianni CM; Kaiser SJ; Günther F
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1547-1552. PubMed ID: 31152264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.
    Zowawi HM; Syrmis MW; Kidd TJ; Balkhy HH; Walsh TR; Al Johani SM; Al Jindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Sidjabat HE; Baz O; Trembizki E; Whiley DM; Paterson DL
    J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem-resistant
    Huang W; Wei X; Xu G; Zhang X; Wang X
    Front Public Health; 2023; 11():1088262. PubMed ID: 36844819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region.
    Al-Orphaly M; Hadi HA; Eltayeb FK; Al-Hail H; Samuel BG; Sultan AA; Skariah S
    mSphere; 2021 May; 6(3):. PubMed ID: 34011686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999-2012.
    Logan LK; Gandra S; Mandal S; Klein EY; Levinson J; Weinstein RA; Laxminarayan R;
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):352-359. PubMed ID: 27856730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight-year trends in the relative isolation frequency and antimicrobial susceptibility among bloodstream isolates from Greek hospitals: data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance - WHONET-Greece, 2010 to 2017.
    Polemis M; Tryfinopoulou K; Giakkoupi P; ; Vatopoulos A
    Euro Surveill; 2020 Aug; 25(34):. PubMed ID: 32856583
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Shortridge D; Streit JM; Mendes R; Castanheira M
    Microbiol Spectr; 2022 Apr; 10(2):e0271221. PubMed ID: 35262394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of multi-drug resistant Pseudomonas aeruginosa infections on acute pancreatitis patients.
    Wu D; Lu W; Huang Y; Qin G; Liu H; Xiao J; Peng J
    BMC Infect Dis; 2023 May; 23(1):340. PubMed ID: 37217844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
    Shanthi M; Sekar U
    J Assoc Physicians India; 2009 Sep; 57():636, 638-40, 645. PubMed ID: 20214000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem Resistant
    Qin J; Zou C; Tao J; Wei T; Yan L; Zhang Y; Wang H
    Infect Drug Resist; 2022; 15():2301-2314. PubMed ID: 35517901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?
    Cosentino F; Viale P; Giannella M
    Curr Opin Infect Dis; 2023 Dec; 36(6):564-571. PubMed ID: 37930070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.